Smartwatch-supported Internet-delivered Intervention for Depression

Depression Clinical Trial

Official title:

Integration of a Smartwatch Within an Internet-delivered Intervention for Depression: a Feasibility Randomized Controlled Trial on Acceptance

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04568317
• Other study ID #: 20/WA0206
• Status: Completed
• Phase: N/A
• Start date: November 30, 2020
• Est. completion date: September 1, 2021

Study information

• Verified date: November 2022
• Source: Silver Cloud Health
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The current study seeks to investigate the acceptance of the use of a smartwatch in an internet-delivered Cognitive Behavioural Therapy (CBT) based intervention for depression.

Description:

Eligible patients (n=70) will be invited to use the supported intervention over an 8-week period. Participants who have indicated consent will be randomised in two arms: iCBT intervention - treatment as usual (n=35) and iCBT intervention with smartwatch (n=35). Participants in the smartwatch group will be lent a smartwatch for the duration of treatment, with an app allowing them to monitor their mood in the moment, and keep track of their daily sleep and activity level. All participants will be asked to complete an acceptance questionnaire regarding the technology at three time points: before first use, at 3 weeks, and 8 weeks. This study will contribute to the growing literature on acceptance of technology supporting mental health interventions worldwide. The results may help to establish criteria for patient acceptance of the smartwatch technology as a treatment enhancer in the context of mental health interventions.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 71
• Est. completion date: September 1, 2021
• Est. primary completion date: September 1, 2021
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 80 Years

Eligibility

Inclusion Criteria:

• Eligible for the internet-delivered CBT intervention 'Space from Depression'
• Own a compatible mobile device (iPhone 6 or upper)

Exclusion Criteria:

• Suicidal intent/ideation; score >2 on PHQ-9 question 9
• Psychotic illness
• Alcohol or drug misuse
• Previous diagnosis of an organic mental health disorder
• Currently in psychological treatment for depression symptoms
• Unstable medication regimens

Related Conditions & MeSH terms

• Depression
• Depressive Disorder

Intervention

Behavioral:
• Space from Depression
This is a 7-module internet-based CBT program. The structure and content of the modules follow evidence-based CBT principles; they are structured to incorporate quizzes, videos, psychoeducational content and interactive tools, personalised homework suggestions and summaries. One of the interactive tools is the mood monitor, where users are encouraged to monitor their mood and reflect on several factors that might had influenced it. Clients are allocated to a psychological wellbeing practitioner (PWP). The PWP is responsible for monitoring and guiding the client's progress throughout the intervention. Over the course of the 8 week supported intervention period, on 6 separate occasions the PWP will review participants progress, leaving feedback for them and responding to the work they have completed. The basic share level allows PWP is to view users' goals for the week, key messages and progress points. Each PWP will provide post-session feedback of between 10 and 15 minutes per session.

Device:
• Mood Monitor watch app
The Mood Monitor watch app will allow in-the-moment self-report of patients' mood and automated monitoring of their sleep and activity level. This data will be integrated into the existing Mood Monitor tool within the participant's Space from Depression program. During the intervention, prompts to record mood data will appear on the watch app; participants will be encourage to choose the frequency and time ranges to receive prompts. The watch app main screen will provide a daily and weekly visualisation of participant's mood, bedtime, hours slept and steps count, and visual cues on their progress. Participants will receive encouragement prompts to reward frequent and consistent self-report of mood over time and a good sleep hygiene. Finally, the app "Tips to Stay Well" feature will allow participants to go through a list of lifestyle-related tips extracted from the Space from Depression program.

Locations

Country	Name	City	State
United Kingdom	Berkshire Healthcare NHS Foundation Trust	Bracknell	Berkshire

Sponsors (3)

Lead Sponsor	Collaborator
Silver Cloud Health	Berkshire Healthcare NHS Foundation Trust, University of Dublin, Trinity College

Country where clinical trial is conducted

United Kingdom, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Patient acceptance (questionnaire)	All participants will be asked to fill in the Acceptability Questionnaire (AQ) upon consent, at 3 weeks, and at 8 weeks. These measurement points are aligned with Nadal et al. (2020) Technology Acceptance Lifecycle model. The questionnaire is based on the acceptance factors identified by Kim & Park (2012). The wording of the AQ is adapted to the technology in question (smartwatch vs mobile/desktop app). Participants will rate each statement on a 5-point Likert Scale. The 8-week AQ contains a series of open-ended questions for the smartwatch group to explore additional factors that might influence the watch app acceptance (privacy protection, resistance to change, etc.).	Upon consent, at 3 weeks, and at 8 weeks
Primary	Patient acceptance (interview)	Participants in the smartwatch group who have indicated consent in taking part in the follow-up interview will be contacted after answering the final acceptance questionnaire.	8 weeks
Primary	Patient acceptance (Satisfaction with Treatment measure)	The SAT (Richards et al, 2013) will be used to assess patient satisfaction with the intervention. This 5-item questionnaire has been used previously to evaluate different aspects of patient satisfaction and experience with the 'Space from Depression' intervention (Richards et al, 2013).; Score varies from 0 to 20; a higher score indicates a better outcome. The score is informed by 2 open-ended questions at the end of the questionnaire.	Immediately after the intervention
Secondary	Patient Health Questionnaire-9 (PHQ-9)	The PHQ-9 is a nine-item self-report measure of depression (Kroenke et al, 2001; Spitzer et al, 1999) that has been widely used in research and is employed as a clinical outcome measure in IAPT as part of its minimum dataset. The PHQ-9 items reflect the diagnostic criteria for depression outlined by the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (A.P. Association, 2013).; Score varies from 0 to 27; a higher score indicates a worse outcome.	Baseline - At every meeting between participant and supporter - Immediately after the intervention
Secondary	Generalized Anxiety Disorder-7 (GAD-7)	The GAD-7 (Spitzer et al, 2006) is used nationally as a screening and outcome measure in IAPT and is part of the minimum dataset. The seven items measuring anxiety symptoms and severity reflect the DSM-Fifth Edition diagnostic criteria for GAD (A.P. Association, 2013).; Score varies from 0 to 21; a higher score indicates a worse outcome.	Baseline - At every meeting between participant and supporter - Immediately after the intervention
Secondary	Work and Social Adjustment Scale (WSAS)	This is a five-item self-report questionnaire of functional impairment (Mundt et al, 2002) that is employed nationally as an outcome measure in IAPT. It examines the experiential impact of a disorder across different life domains from the perspective of the service users. The questionnaire examines the degree of impairment caused by a disorder on a daily basis across five dimensions: work, social life, home life, private life, and close relationships.; Score varies from 0 to 40; a higher score indicates a worse outcome.	Baseline - At every meeting between participant and supporter - Immediately after the intervention
Secondary	Usage of the program	Usage data in terms of time spent in the platform, number of logins, number of tools used, percentage viewed, and number of reviews will be collected. Also, the amount of mood monitor entries, sleep and activity data will be extracted. Approximate activity levels (graded 1 to 5) and sleep patterns will be analyzed to explore the changes over time.	at treatment completion, in average 8 weeks.